Though commonly associated with slimmer physiques, research shows that exercise may only have modest effects on weight loss. However, it may be the key [...]

The UK's medicines regulator, the MHRA, approved orforglipron (brand name Foundayo) on 10 August 2026, making Britain the first in Europe to approve the [...]

The King's Fund reports that England now has 7.2 million more adults living with obesity than it would if rates had held at 1993 [...]

Early-onset type 2 diabetes, meaning a diagnosis of type 2 diabetes before age 40, is associated with aggressive disease progression, long-term health burden and [...]

MPs are asking the government to put preventing obesity in future generations before the interests of the food and drink industry. In a new report, [...]

Inulin propionate ester (IPE) is a dietary fibre that has been developed and tested by scientists at Imperial College London and SUERC, Centre for the [...]

The researchers aimed to provide an up-to-date evidence summary about the comparative benefits and harms of drugs for adults with overweight or obesity. The study [...]

Researchers found significant variation in obesity prevalence by age, sex, socioeconomic status and ethnicity. This ranged from 4·3% in the least socioeconomically deprived white [...]

The Food Foundation's Broken Plate report documents: the health of the UK food system; how it impacts lives; and what must change to ensure [...]

The new study published in May's Nature Medicine journal included 376 people in the United States who had been taking tirzepatide (Mounjaro) or semaglutide (Wegovy) for [...]